Australia proposes reforming ad oversight, adding medtech

06/9/2013 | Clinica

Pharmaceutical companies and other stakeholders have until July 12 to comment on proposals by the Australian Therapeutic Goods Administration to revise the approval process for various kinds of OTC-drug advertising -- to require pre-approval for ads on pay TV, for example -- and to cover ads for medical devices. In response, the Medical Technology Association of Australia came out against pre-approval for medtech ads and stressed the need for strengthening the timeliness and effectiveness of the oversight and complaints processes.

View Full Article in:

Clinica

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX